Q2 2021 Results - Reimagining Medicine slide image

Q2 2021 Results - Reimagining Medicine

Participants Company overview Pharmaceuticals Oncology Financial review Conclusion Appendix References Susanne Schaffert President, Novartis Oncology 25 Investor Relations | Q2 2021 Results 1 NOVARTIS | Reimagining Medicine
View entire presentation